Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHalma Regulatory News (HLMA)

Share Price Information for Halma (HLMA)

Share Price is delayed by 15 minutes
Get Live Data
4,664.00    -214.00 (-4.39%)
Bid:
4,682.00
Ask:
4,686.00
Spread: 4.00 (0.085%)
Market Cap: £17.62b
HLMA Live PriceLast checked at - London Stock Exchange

Intraday Halma Share Chart

Interim Management Statement

11 Feb 2010 07:00

RNS Number : 9787G
Halma PLC
11 February 2010
 



Halma p.l.c.

 

Interim Management Statement

 

11 February 2010

 

 

Halma, the leading safety, health and sensor technology group today makes an Interim Management Statement prior to its financial year end on 3 April 2010. This Interim Management Statement covers the period from 4 October 2009 to date.

 

Based on current trading and forecasts, the Board expects profit (before amortisation of acquired intangibles) for the full year to be higher than the top of the range of market expectations. The Board believes the current range of market expectations is £78.9million to £82.1million (2008/09 profit before amortisation of acquired intangibles: £79.1million).

 

During the past four-month period, average weekly revenue was 3% higher than we reported for the first half-year ending 3 October 2009. Order intake was ahead of revenue, continuing the positive trend of the first half. The impact of currency exchange rate movements has been broadly neutral relative to the first half.

 

In recent months, profitability has improved in all our three sectors, each benefiting from the actions taken earlier in 2009 to reduce fixed and variable costs.

 

Health and Analysis continues to perform strongly and is expected to report growth in both revenue and profit for the full year. Demand levels in Infrastructure Sensors have continued to be resilient and this, combined with a lower cost base, should enable it to achieve profit growth for the full year. In Industrial Safety, trading has improved gradually although full year revenue and profit are still expected to be below last year's record levels.

 

On 22 January 2010, we announced the acquisition of SphereOptics, LLC for an initial cash consideration of $2.5m (£1.5m) with a deferred purchase consideration of up to $3.5m (£2.1m) based on the growth in profit before tax for the period ending March 2012. SphereOptics manufactures and distributes precision products for use in high technology light measurement applications. Its integration within our Health and Analysis business is proceeding to plan.

 

There have been no material events or transactions impacting the Group's financial position which remains robust and cash generation continues to be strong. We remain well placed to acquire businesses which meet our demanding requirements.

 

The results for the financial year ending 3 April 2010 are expected to be released on 22 June 2010.

 

 

For further information, please contact:

 

Halma p.l.c.

Andrew Williams, Chief Executive

Kevin Thompson, Finance Director

Tel: +44 (0)1494 721111

 

Hogarth Partnership Limited

Rachel Hirst/Andrew Jaques

 

Tel: +44 (0)20 7357 9477

 

Notes:

 

1.

This Interim Management Statement has been prepared solely to provide additional information to the shareholders of Halma p.l.c., in order to meet the requirements of the UK Listing Authority's Disclosure and Transparency Rules. It should not be relied on by any other party, for other purposes. Forward-looking statements have been made by the Directors in good faith using information available up until the date that they approved this statement. Forward-looking statements should be regarded with caution because of the inherent uncertainties in economic trends and business risks.

 

2.

A copy of this announcement, together with other information about Halma, may be viewed on its website: www.halma.com

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMZVGRGGZM
Date   Source Headline
28th May 20267:15 amRNSExecutive Board changes
13th Apr 20267:00 amRNSAcquisition
12th Mar 20267:00 amRNSTrading Update
13th Jan 20269:18 amRNSDirector/PDMR Shareholding
9th Jan 20261:26 pmRNSDirector/PDMR Shareholding
9th Jan 20267:00 amRNSAcquisition
5th Dec 20257:00 amRNSAcquisition
20th Nov 20257:00 amRNSHalf Year Results
1st Oct 20252:00 pmRNSDirector/PDMR Shareholding
26th Sep 202510:19 amRNSDirector/PDMR Shareholding
25th Sep 20257:00 amRNSTrading Update
26th Aug 20257:00 amRNSAcquisition
24th Jul 20252:15 pmRNSResult of AGM
30th Jun 202511:30 amRNSDirector/PDMR Shareholding
25th Jun 20258:30 amRNSAGM - Revised Form of Proxy
24th Jun 20259:20 amRNSDirector/PDMR Shareholding
20th Jun 20255:15 pmRNSAnnual Financial Report
18th Jun 20254:47 pmRNSDirector/PDMR Shareholding
12th Jun 20257:00 amRNSFull Year Results
16th May 20257:00 amRNSDirectorate Change
28th Mar 20251:10 pmRNSDirector/PDMR Shareholding
21st Mar 20252:00 pmRNSDirectorate Change
13th Mar 20257:00 amRNSTrading Update
28th Feb 20254:29 pmRNSDirector/PDMR Shareholding
14th Jan 20252:05 pmRNSDirector/PDMR Shareholding
8th Jan 20257:00 amRNSAppointment of Chief Financial Officer
28th Nov 202410:04 amRNSDirector/PDMR Shareholding
22nd Nov 20243:30 pmRNSDirector/PDMR Shareholding
22nd Nov 20243:26 pmRNSDirector/PDMR Shareholding
21st Nov 20247:00 amRNSHalf Year Results
18th Nov 20247:00 amRNSAcquisition
6th Nov 20242:34 pmRNSDirector Declaration
2nd Oct 20249:20 amRNSDirector/PDMR Shareholding
26th Sep 20247:00 amRNSTrading Update
24th Sep 20249:45 amRNSDirector/PDMR Shareholding
3rd Sep 20249:15 amRNSPDMR Shareholding
25th Jul 20241:51 pmRNSResult of AGM
24th Jul 20249:15 amRNSDirector/PDMR Shareholding
17th Jul 202412:46 pmRNSDirector Declaration
1st Jul 20249:51 amRNSDirector/PDMR Shareholding
27th Jun 20247:00 amRNSAcquisition
25th Jun 20243:00 pmRNSDirector/PDMR Shareholding
24th Jun 20245:26 pmRNSAnnual Financial Report
13th Jun 20247:00 amRNSFull Year Results
1st May 20247:00 amRNSAcquisition
19th Mar 20243:53 pmRNSDirector/PDMR Shareholding
14th Mar 20247:00 amRNSTrading Update
4th Mar 20247:00 amRNSAcquisition
21st Feb 20244:17 pmRNSDirector/PDMR Shareholding
30th Jan 20247:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.